These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 467632)
1. QSAR in a series of muscarinic agents. Pratesi P; Villa L; Ferri V; De Micheli C; Grana E; Grieco C; Silipo C; Vittoria A Farmaco Sci; 1979 Aug; 34(8):657-65. PubMed ID: 467632 [TBL] [Abstract][Full Text] [Related]
2. Correlation analysis in a set of X-benzyltrimethylammonium derivatives with antimuscarinic activity. De Amici M; De Micheli C; Pratesi P; Grana E; Santagostino Barbone MG; Cappello B; Silipo C; Vittoria A Farmaco Sci; 1987 Jun; 42(6):409-24. PubMed ID: 3653389 [TBL] [Abstract][Full Text] [Related]
3. Quantitative structure-activity study for inhibition of acetylcholinesterase by m-substituted benzyltrimethylammonium salts. Miyagawa H; Fujita T Farmaco Sci; 1982 Dec; 37(12):797-804. PubMed ID: 7152015 [TBL] [Abstract][Full Text] [Related]
4. Relation between structure and muscarinic activity III. Synthesis and cholinergic activity of some-onium compounds related to 2-methyl-4-trimethylammoniomethyl-1,3-dioxolane iodide. Elferink JG; Salemink CA Arzneimittelforschung; 1975; 25(12):1858-60. PubMed ID: 1243653 [TBL] [Abstract][Full Text] [Related]
5. Cholinergic compounds. III - Synthesis and biological activity of epi-desmethyldesethermuscarine, desmethyldesethermuscarine and desmethyldesethermuscarone. Melchiorre C; Gualtieri F; Giannella M; Pigini M; Cingolani ML; Gamba G; Pigini P; Rossini L Farmaco Sci; 1975 Apr; 30(4):287-99. PubMed ID: 1183606 [TBL] [Abstract][Full Text] [Related]
6. Contraction of the urinary bladder by muscarinic ganglionic stimulants: possible existence of muscarinic receptor sites on its parasympathetic ganglia. Saxena PR Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):16-28. PubMed ID: 4403681 [No Abstract] [Full Text] [Related]
7. [Possibility of substance selective action on the m-cholinoreceptors of a specific site]. Kharkevich DA; Skoldinov AP; Samăilov DN; Shorr VA Farmakol Toksikol; 1980; 43(6):645-52. PubMed ID: 7449999 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the action of acetylcholine and acetylcholine mustard (chloroethylmethylaminoethyl acetate) on muscarinic and nicotinic receptors. Hudgins PM; Stubbins JF J Pharmacol Exp Ther; 1972 Aug; 182(2):303-11. PubMed ID: 4538023 [No Abstract] [Full Text] [Related]
9. A dual action of muscarinic partial agonists on pupil size of rabbit. Terashima E; Takayanagi I; Ohashi M J Pharmacobiodyn; 1982 Dec; 5(12):1024-6. PubMed ID: 7169605 [No Abstract] [Full Text] [Related]
10. Comparison of the muscarinic receptor binding activity of some tertiary amines and their quaternary ammonium analogues. Ehlert FJ; Jenden DJ Mol Pharmacol; 1984 Jan; 25(1):46-50. PubMed ID: 6708935 [TBL] [Abstract][Full Text] [Related]
11. Cholinergic compounds. V - New synthesis and further pharmacological evaluation of desethermuscarine. Melchiorre C; Gualtieri F; Giannella M; Pigini M; Cingolani ML; Gamba G; Pigini P; Rossini L Farmaco Sci; 1975 Apr; 30(4):300-10. PubMed ID: 1183607 [TBL] [Abstract][Full Text] [Related]
12. QSAR in a series of muscarinic agents. Note II - Pyridine and furan derivatives. Pratesi P; Villa L; Ferri V; de Micheli C; Grana E; Santagostino Barbone MG; Grieco C; Silipo C; Vittoria A Farmaco Sci; 1980 Aug; 35(8):621-35. PubMed ID: 7450050 [TBL] [Abstract][Full Text] [Related]
13. [Molecular rigidity of ammonium compounds as a necessary condition for selective action on skeletal muscle cholinoreceptors]. Danilov AF; Starshinova LA; Fedorov DIu; Shelkovnikov SA Dokl Akad Nauk SSSR; 1981; 258(5):1238-42. PubMed ID: 6114826 [No Abstract] [Full Text] [Related]
14. [Interaction of N-methyl and N-butyl scopolammonium and some parasympathomimetics on cholinergic receptors in the jejunum of the rat]. Labrid C; Dureng G; Streichenberger G Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):175-92. PubMed ID: 4441181 [No Abstract] [Full Text] [Related]
15. [Structure-activity relationship in the series of muscarinic acetylcholine receptor antagonists: four types of antagonist-receptor binding]. Tropsha AE; Nizhniĭ SV; Iaguzhinskiĭ LS Bioorg Khim; 1985 Oct; 11(10):1402-16. PubMed ID: 4074400 [TBL] [Abstract][Full Text] [Related]
16. Stimulant action of 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343) on muscle spindles in the rat. Kucera J; Smith CM Eur J Pharmacol; 1972 May; 18(2):287-90. PubMed ID: 4260964 [No Abstract] [Full Text] [Related]
17. Neurochemical and behavioural effects of muscarinic acetylcholine receptor agonists. Spencer DG; van Rooijen LA; Horváth E; Dompert W; Traber J Trends Pharmacol Sci; 1988 Feb; Suppl():61-8. PubMed ID: 3074540 [No Abstract] [Full Text] [Related]
18. Changes in vascular reactivity and renal hemodynamics induced by benzyltrimethylammonium bromide (BTM). Cronnelly R; Strandhoy JW; Dretchen KL; Sweet CS; Long JP J Pharmacol Exp Ther; 1972 Jan; 180(1):13-23. PubMed ID: 4622010 [No Abstract] [Full Text] [Related]
19. QSAR in a series of muscarinic agents. Note V. New sets of rigid and flexible ligands. Pratesi P; Villa L; Ferri V; De Micheli C; De Amici M; Grana E; Santagostino Barbone MG; Silipo C; Vittoria A; Cappello B Farmaco Sci; 1984 Mar; 39(3):171-88. PubMed ID: 6714413 [TBL] [Abstract][Full Text] [Related]
20. Relationships between chemical structure and cholinergic activities of furmethides and potentiation of these activities by physostigmine. Chaturvedi AK; Rowell PP; Sastry BV Pharmacol Res Commun; 1981 Oct; 13(9):829-45. PubMed ID: 7335761 [No Abstract] [Full Text] [Related] [Next] [New Search]